A 2006 meta Evaluation concluded that in comparison with other proton pump inhibitors, esomeprazole confers a modest overall advantage in esophageal therapeutic and symptom relief. When damaged down by sickness severity, the benefit of esomeprazole relative to other proton pump inhibitors was negligible in people with mild disorder (selection needed https://zaneteltz.blogunteer.com/8593475/an-unbiased-view-of-thuoc-esomeprazole-40mg